Cheyenne Regional Medical Center Is Offering Next-Generation Robotic Bronchoscopy for Early Diagnosis and Treatment of Lung Cancer

May 5, 2025 — Residents of Cheyenne and surrounding areas will now have access to a cutting-edge robotic platform as part of Cheyenne Regional’s fight against lung cancer. The health system today announced that it is one of the first in Wyoming to use the Galaxy System for the earlier diagnosis of lung cancer.

Lung cancer is the second most common cancer in the United States and the leading cause of cancer deaths in the country. But today, it can be difficult for physicians to properly find and biopsy lung nodules, delaying diagnosis and complicating treatment.

The Galaxy System from Noah Medical is designed in collaboration with physicians to improve lung cancer diagnosis. It is a state-of-the-art robotic platform that enables physicians to navigate and locate lung nodules with greater precision and accuracy than current robotic platforms. Its Tool-in-Lesion (TiLT+) Technology has been shown to achieve 100% successful navigation to lesions, 100% tool-in-lesion accuracy, and up to approximately 95% diagnostic yield.

With the Galaxy System, Cheyenne Regional physicians can now diagnose and treat lung nodules sooner and reduce the potential for infection from improperly cleaned reusable scopes, thanks to the system’s single-use bronchoscope.

“We are proud to be the first hospital in Wyoming to offer this innovative technology,” said Dr. Rage Geringer, a critical care and pulmonology physician at Cheyenne Regional Medical Group. “Bringing the Galaxy System to our community allows us to find and biopsy lung nodules earlier and more precisely, which means better outcomes for our patients. I’m honored to help lead this important advancement in care right here at home.”